Optical Coherence Tomography Angiography Reveals Distinct Retinal Structural and Microvascular Abnormalities in Cerebrovascular Disease

Cerebrovascular disease (CeVD) is one of the leading global causes of death and severe disability. To date, retinal microangiopathy has become a reflection of cerebral microangiopathy, mirroring the vascular pathological modifications in vivo. To evaluate the retinal structure and microvasculature in patients with CeVD, we conducted a cross-sectional study in Zhongshan Ophthalmic Center and Department of Neurology of Third Affiliated Hospital, Sun Yat-sen University using optical coherence tomography angiography (OCTA). CeVD patients (n = 121; 238 eyes) and healthy controls (n = 44; 57 eyes) were included in the analysis. The CeVD group showed significant thinning of the peripapillary retinal nerve fiber layer (pRNFL) thickness in the temporal and nasal quadrants, and thinning of the macular ganglion cell-inner plexiform layer (GC-IPL) in the inferior quadrant, while macular microvasculature reduction was prominent in all nine quadrants. There were significant correlations between OCTA parameters, visual acuity, and transcranial doppler parameters in the CeVD group. The specific structural parameters combining microvasculature indices showed the best diagnostic accuracies (AUC = 0.918) to discriminate CeVD group from healthy controls. To conclude, we proved that OCTA reveals specific patterns of retinal structural changes and extensive macular microvascular changes in CeVD. Additionally, these retinal abnormalities could prove useful disease biomarkers in the management of individuals at high risk of debilitating complications from a cerebrovascular event.

Introduction

Cerebrovascular disease (CeVD), affecting blood vessels that supply the brain, is one of the leading global causes of death and severe disability (Menken et al., 2000; Kochanek et al., 2019; Li et al., 2020). Despite extensive research on neuroimaging techniques, identifying patients at high risk of cerebrovascular complications is based on limited data that emphasize brain morphological changes (Paradise et al., 2018). In order to optimize treatment plans, a major research drive is the identification of potential biomarkers in other organs which reflect the underlying small vessel changes contributing to disease besides the brain (Arnould et al., 2018).

There is mounting evidence that the retina provides an accurate window into cerebrovascular and systemic vascular conditions (Stenkamp, 2015; Miesfeld and Brown, 2019; Rim et al., 2020). This is unsurprising given that the retina and the cerebrum share a common neurodevelopmental origin. Embryologically, besides the cerebrum, the forebrain neuroectoderm also contributes to the development of the retinal pigment epithelium and neural retina (Stenkamp, 2015; Miesfeld and Brown, 2019). Anatomically, both the anterior brain and the retina are supplied by the internal carotid artery (ICA; Rim et al., 2020). Although the brain vasculature has a complex intricate architecture, it has been suggested that retinal microangiopathy is a reflection of cerebral microangiopathy, mirroring the vascular pathological modifications in vivo (Goto et al., 1975).

The links between retinal parameters and CeVD have been extensively evaluated (Wong et al., 2001, 2002; Couper et al., 2002; Mitchell et al., 2005; McGeechan et al., 2009; Cheung et al., 2010; Hanff et al., 2014; Rajanala et al., 2020). Three major groups of retinal changes have been connected to CeVD, namely, features of hypertensive retinopathy, clinical retinal diseases, and retinal microvascular abnormalities (including arteriovenous nicking, focal arteriolar narrowing, and decreased arteriole-to-venule ratio; Wong et al., 2001; Mitchell et al., 2005; Cheung et al., 2010; Hanff et al., 2014). In addition, retinal microvascular abnormalities are correlated with an increased risk of stroke and stroke mortality (Wong et al., 2002). Longitudinal studies indicate that retinal vascular changes can predict patients at risk of progression to clinical CeVD (McGeechan et al., 2009; Rajanala et al., 2020). However, most studies were conducted using retinal photography (Wong et al., 2001; Couper et al., 2002; Mitchell et al., 2005; Cheung et al., 2010; Hanff et al., 2014), which cannot provide direct quantitative information on optic nerve structure and retinal vascular flow, and is less sensitive in the detection of retinal irregularities compared with optical coherence tomography (OCT; Goebel and Franke, 2006; Ouyang et al., 2013).

Optical coherence tomography angiography (OCTA) allows real-time quantitative evaluation of optic nerve structure and retinal vascular flow yielding greater image acquisition rates and sensitive measurements (Jia et al., 2015). Advanced OCTA techniques have become essential in the decision-making process of retinal disease management and can be used to identify CeVD patients (Kashani et al., 2017). Currently, the association between CeVD and abnormal findings in OCTA has not yet been investigated. In this study, we used OCTA to define whether specific patterns of damage involving the optic nerve and macular microvasculature is observed in patients with CeVD. The main outcome measures were peripapillary retinal nerve fiber layer (pRNFL) and macular ganglion cell-inner plexiform layer (GC-IPL) thickness, and macular vessel density (VD), and perfusion density (PD) in the superficial capillary plexus. We hypothesized that retinal structural and microvascular abnormalities in CeVD patients are quantifiable by OCTA, and these abnormalities could be considered as surrogate pathological markers for CeVD.

Materials and Methods

Subject Recruitment

Participants were volunteers who benefited from an OCTA examination from December 3, 2019 to May 3, 2020, and were recruited from Zhongshan Ophthalmic Center and Department of Neurology of The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. Written informed consent was obtained from all the participants. This study was approved by the Ethics Committee of Zhongshan Ophthalmic Center, Sun Yat-sen University (ethics board approval number: 2019KYPJ163), and it was conducted in accordance with the tenets of the Declaration of Helsinki.

Cerebrovascular disease patients were included if they were ≥18 years old. Two neurologists confirmed the diagnosis of CeVD, which in this study included intracranial hemorrhage and cerebral ischemia. Classification is based on the International Statistical Classification of Diseases and Related Health Problems 11th Revision from 2018 onward. Patients were excluded for the following reasons: (1) subjects diagnosed with other systemic diseases, including diabetes; (2) ocular diseases (including myopia (<-6 diopter), hyperopia (>6 diopter), the opacity of refractive media, age-related macular degeneration, glaucoma, hypertensive or diabetic retinopathy, optic disk pathology, and other eye pathology) or previous ocular surgery; (3) age < 18 years old; and (4) inability to provide informed consent. The criteria for inclusion in the healthy control group were no history of CeVD or other ocular and neurological diseases, with a normal fundus and visual acuity.

Clinical Evaluation

All participants underwent an extensive ophthalmologic examination, including habitual visual acuity testing with a 6 m Snellen chart, slit-lamp biomicroscopy, fundus examination, fundus photography, and OCTA scans (Cirrus 5000, version 10.0; Zeiss Meditec, California, United States). All ophthalmological examinations were performed by a single well-trained clinician. For the visual acuity measurements, the refractive correction was used with the patient’s own spectacles under a chart luminance about 160 cd m^–2. The standard termination rule is when a patient makes four or more mistakes on a line of five letters. Intraocular pressure measurement with Goldmann applanation tonometry, gonioscopy, and visual field testing by standard automated perimetry (SAP, Humphrey Field Analyzer; 30-2 Swedish interactive threshold algorithm; Carl Zeiss Meditec, Jena, Germany) were only considered to exclude suspected glaucoma or other retinopathy. The axial length measurement was only considered to exclude myopia (<-6 diopter) or microphthalmia.

All patients with CeVD were tested with computerized tomography scans and magnetic resonance imaging scans. The common carotid artery (CCA), ICA, and ophthalmic artery (OA) blood velocities were determined in some CeVD patients who agreed and were able to undergo bilateral 2 MHz transcranial doppler ultrasound (DWL, Doppler Box, Singen, Germany). The transcranial doppler ultrasound was performed by one experienced neurophysiology technician. Peak systolic velocity and mean velocity were recorded in cm/s.

OCTA Acquisition and Processing

Optical coherence tomography angiography imaging was performed using a high-definition OCT and AngioPlex device (Cirrus 5000, version 10.0; Zeiss Meditec, California, United States) as described previously (Xiao et al., 2020a,b; Zhang et al., 2020). Briefly, an optic disk cube 200 × 200 scan mode was used for the pRNFL measurements, a macular cube with 512 × 128 scan mode was used to determine the macular thickness and GC-IPL thickness measurements, and angiography imaging was conducted centered at the macula with the 6 × 6 mm scan pattern (Figure 2A).

Peripapillary retinal nerve fiber layer thickness was measured using 3.46 mm diameter circles around the optic disk. The average pRNFL thickness and the thicknesses of the four-quadrant sectors (superior, temporal, inferior, and nasal) were analyzed. The GC-IPL thickness parameters evaluated were the average thickness within a 14.13 mm² elliptical annular area region and the thicknesses in six quadrant sectors (superior, temporal-superior, temporal-inferior, inferior, nasal-inferior, and nasal-superior). Angiography scans were analyzed using Cirrus OCTA software (AngioPlex, version 10.0; Carl Zeiss Meditec). VD was calculated from the total length of perfused vasculature per unit area in a region of measurement, while PD was calculated from the total area of perfused vasculature per unit area in a region of measurement. The central foveal region was a region with a diameter of 1 mm, and the inner and outer rings had outer diameters of 3 and 6 mm, respectively. The VD and PD values of the nine quadrant sectors, the central, inner, and outer rings and the whole area were analyzed. The VD, PD and the foveal avascular zone (FAZ) of the superficial capillary plexus (SCP) were automatically measured by the in-built software from Carl Zeiss Meditec using optical microangiography algorithms. The software only calculates values for the SCP, which spans from the internal limiting membrane to the inner plexiform layer. The absence of motion artifacts was defined as no vessel doubling, vessel discontinuity/misalignment or lateral vessel displacement in the OCTA image. Images with a signal strength <7 and those with poor centration or segmentation errors were excluded from data analysis.

Statistical Analyses

All statistical analyses were performed using software (SPSS, ver. 22.0; SPSS Inc., Chicago, IL, United States). The generalized estimating equations (GEE) method was used to adjust for age, gender, and the inter-eye correlation from the same participant. Pearson’s correlation was used to assess the associations between the OCTA parameters and the correlations between the OCTA values, visual acuity, and transcranial doppler values after testing using the GEE models. Logistic regression was employed to combine the diagnostic parameters into composite diagnostic indices. The area under the receiver operating characteristic curve (AUC) was used to calculate the diagnostic power of the diagnostic parameters. To compare the diagnostic capabilities of the parameters, the AUCs were compared using the method described by DeLong and colleagues (DeLong et al., 1988). A P value < 0.05 was considered statistically significant.

Data Availability

The data that support the findings of this study is available from the corresponding author upon reasonable request.

Results

Demographic Data

In total, the study enrolled 238 eyes of 121 subjects with CeVD and 57 eyes of 44 healthy controls in the final analysis (Figure 1). The age of the CeVD subjects was 56.00 ± 11.27y (mean ± SD), and the age of the healthy controls was 53.17 ± 7.29y (mean ± SD). Among the participants included in the final analysis, the causes of CeVD were intracranial hemorrhage (41 subjects; 79 eyes) and cerebral ischemia (80 subjects; 159 eyes). Table 1 shows the baseline characteristics of the study population.

FIGURE 1

Figure 1. Flow diagram of the study population.

TABLE 1

Table 1. Demographic data and clinical characteristics.

Patterns of Loss in Retinal Structure and Microvasculature

The structural and microvascular parameters were evaluated using GEE models to adjust for age, sex, and within-subject inter-eye correlations (Table 2). The CeVD group showed significant thinning of the pRNFL at the temporal (P = 0.015) and nasal quadrants (P = 0.004). At the macula, the thickness of the GC-IPL was significantly reduced in the inferior quadrant in the CeVD group (P = 0.028). In addition, the CeVD group showed significantly reduced macular VD and PD compared with the healthy controls in all nine quadrants (Figure 2B). No significant differences were found in the whole macular thickness or the size of FAZ between patients with CeVD and healthy controls.

TABLE 2

Table 2. Comparison of optical coherence tomography angiography parameters between patients with CeVD and healthy controls.

FIGURE 2

Figure 2. Retinal structural and microvasculature measurements. (A) Diagram of peripapillary and macular measurements using OCTA. Peripapillary retinal nerve fiber layer thickness was divided into four sectors, macular ganglion cell-inner plexiform layer thickness was divided into six sectors and macular microvasculature was divided into nine sectors. (B) Topographic damage in CeVD eyes. The thickness of the pRNFL was significantly reduced in the temporal and nasal quadrants, while the thickness of the GC-IPL was significantly reduced in the inferior quadrant. The CeVD group showed significantly reduced macular vessel density and perfusion density in all nine quadrants compared with the healthy controls. Macular microvasculature was measured in the superficial capillary plexus. Abbreviations: CeVD, cerebrovascular disease; S, superior; T, temporal; I, inferior; N, nasal; TS, temporal-superior; TI, temporal-inferior; NS, nasal-superior; NI, nasal-inferior; SO, superior-outer; TO, temporal-outer; IO, inferior-outer; NO, nasal-outer; SI, superior-inner; TI, temporal-inner; II, inferior-inner; NI, nasal-inner; and C, central.

Correlation Analysis Between OCTA, Visual Function and Transcranial Doppler Parameters

Since VD was strongly correlated with PD (r = 0.991, P < 0.0001), VD was used as a representative microvasculature manifestation in the following analysis. In CeVD, visual acuity was significantly correlated with the average pRNFL thickness (r = 0.194, P = 0.039). There was also a significant correlation between visual acuity and the superior-outer quadrant of the VD (r = 0.276, P = 0.018). No statistically significant correlations were found between visual acuity and the thickness of GC-IPL or the size of the FAZ area.

In addition, in 41 patients (33.9%) who finished the transcranial doppler ultrasound examinations, the peak velocity of the CCA was significantly correlated with the central VD (r = 0.423, P = 0.028, respectively). The peak velocity of the OA was significantly correlated with superior quadrant of the pRNFL (r = 0.351, P = 0.031). In addition, a significant correlation was found between visual acuity and the peak velocity of the OA (r = 0.412, P = 0.011).

Diagnostic Accuracy of OCTA Parameters

The diagnostic capability of the OCTA parameters was calculated by the AUCs. GEE models were used to adjust for age, sex, and within-subject inter-eye correlations.

To discriminate CeVD from healthy controls, the structural OCT parameters (pRNFL average thickness and GC-IPL average thickness) combined with the macular angiography parameters (central VD and whole VD) significantly improved the diagnostic accuracy compared to only the structural parameters (P < 0.0001). After selecting the specific quadrants of pRNFL and GC-IPL with the best performance to replace the average thicknesses, the structural OCT parameters (pRNFL average thickness and temporal-superior quadrant thickness of GC-IPL) combined with the macular angiography parameters were the best discriminators between the CeVD and healthy control groups, with a diagnostic accuracy of 0.918 (Figure 3 and Table 3).

FIGURE 3

Figure 3. Diagnostic accuracy of optical coherence tomography angiography parameters in discriminating patients with cerebrovascular disease. AUC for average pRNFL + average GC-IPL = 0.590; AUC for average pRNFL + average GC-IPL + central VD + whole VD = 0.913; and AUC for average pRNFL + TS GC-IPL + central VD + whole VD = 0.918. Abbreviations: AUC, area under the curve; pRNFL, peripapillary retinal nerve fiber layer; GC-IPL, ganglion cell-inner plexiform layer; VD, vessel density; and TS, temporal-superior.

TABLE 3

Table 3. Diagnostic ability of optical coherence tomography angiography parameters in distinguishing between patients with CeVD and healthy controls.

Discussion

Exploration of retinal vessel abnormalities may facilitate early detection for cerebrovascular events, and can potentially become the main targets for preventive and treatment strategies in CeVD (Pantoni, 2010). To the best of our knowledge, this is the first study to employ OCTA to assess the patterns of retinal structural and microvascular changes in patients with CeVD (Rim et al., 2020). In our study cohort, the patterns and severity of retinal structural and microvascular losses differed significantly in patients with CeVD compared with healthy controls. The patient group showed pRNFL thinning that was more severe in the temporal and nasal quadrants, and both VD and PD were significantly decreased in all quadrants in comparison with healthy controls. As expected, there was a significant correlation between visual acuity, retinal structural and microvascular parameters and transcranial doppler parameters in the CeVD group. Although our study should be interpreted as a proof-of-concept requiring independent validation in other patient groups, our data indicate the discrimination capability of OCTA with the identification of specific patterns of loss in the retinal structure and microvasculature of CeVD.

We are not aware of any study that has investigated retinal vascularization by measuring vascular density using OCTA in patients with CeVD. Wong and colleagues found that any retinal abnormalities, including arteriovenous nicking, was associated with incident stroke based on the retinal vessel caliber from fundus photographs (Wong et al., 2001). Consistent with microvascular pathology, these retinal abnormalities are likely associated with various markers of inflammation (such as white blood cell count and fibrinogen concentration) and endothelial dysfunction (such as the concentrations of von Willebrand factor and factor VIII; Wong et al., 2001). Furthermore, a wider retinal venular caliber predicted an increased risk of incident stroke, independent of traditional stroke risk factors, in a meta-analysis of 20,798 participants without diabetes (McGeechan et al., 2009). In addition, a reduction in retinal vascular fractal dimension and increased vascular tortuosity, quantified by several global geometrical parameters, have been associated with an increased risk of local ischemia (Lammie, 2002; Tomita et al., 2005). Looking at the current body of evidence, retinal microvascular lesions, including retinal vessel narrowing and widening secondary to subtle microvascular dysfunction, could be manifestations of persistent microvascular damage affecting the general vasculature, with important implications for cerebral circulation and CeVD risks.

In our study, the decreased retinal vascular density in patients with CeVD could, therefore, be explained by the impairment of the general vasculature. However, our study should carefully interpreted within patients who only suffers from CeVD. The efficacy of OCTA examinations still needs to be proved in a clinical setting, as a number of elderly people are susceptible to co-morbidities as well as the associated neuroinflammation which may easily lead to more extensive and severe retinal changes (Buga et al., 2013; Sandu et al., 2015). Further research with repeated measurements over a longer follow-up period is needed to provide more detailed information about the changes in OCTA metrics in CeVD patients with co-morbidities such as obesity, hypertension, diabetes, and age-associated retinal pathologies. In addition, larger case series are needed to investigate whether OCTA parameters bring additional predictive value to existing CeVD disease risk scores. Furthermore, the present data of visual acuity should be further improved, as logMAR (log of the Minimum Angle of Resolution) charts have been widely recognized for providing much more reliable and discriminative visual acuity measurements than Snellen charts. If our findings can be confirmed, individuals who are found to have lower retinal VD with OCTA might benefit from more stringent monitoring and therapeutic protection to reduce future vascular-related morbidity and mortality.

In summary, we showed quantitative retinal structure and microvasculature parameters could prove useful disease biomarkers for CeVD. Future work will confirm whether CeVD is indeed associated with specific patterns of loss and how the observed abnormalities in the structure and microvasculature of the retina relate to an individual’s overall microvascular status, in particular the risk of a debilitating cerebrovascular event.

Data Availability Statement

The data analyzed in this study is subject to the following licenses/restrictions: Available from HL (e-mail, bGluaHQ1QG1haWwuc3lzdS5lZHUuY24=). Requests to access these datasets should be directed to HL (e-mail, bGluaHQ1QG1haWwuc3lzdS5lZHUuY24=).

Ethics Statement

This study was approved by the Ethics Committee of Zhongshan Ophthalmic Center, Sun Yat-sen University (ethics board approval number: 2019KYPJ163). The patients/participants provided their written informed consent to participate in this study.

Author Contributions

XZ, HX, and CL: equal contribution to the study. HL: conception and design. XZ, LZ, and HX: analysis and interpretation. CL, SL, HX, and XZ: data collection. PY-W-M, YZ, CC, RW, JW, TW, XW, DL, and WQ: critical revision of the manuscript. HL, HX, and PY-W-M: funding. HL and ZL: overall responsibility. All authors contributed to the article and approved the submitted version.

Funding

HL was funded by the National Key R&D Program of China (2018YFC0116500), the National Natural Science Foundation of China (81770967 and 81822010), and the Science and Technology Planning Projects of Guangdong Province (2018B010109008). HX was funded by the Natural Science Foundation of Guangdong Province (2017A030313649). PY-W-M was supported by a Clinician Scientist Fellowship Award (G1002570) from the Medical Research Council (United Kingdom), and also receives funding from Fight for Sight (United Kingdom), the Isaac Newton Trust (United Kingdom), the National Eye Research Centre (United Kingdom), the United Kingdom National Institute of Health Research (NIHR) as part of the Rare Diseases Translational Research Collaboration, and the NIHR Biomedical Research Centre based at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. The opinions, results, and conclusions reported in this article are those of the authors and are independent of the funding sources.

Conflict of Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

All images were acquired by Cirrus HD-OCT 5000 AngioPlex. We hereby give our great thanks to MED Department, Carl Zeiss (Shanghai) Co., Ltd., ZEISS Group for the devices and technical support, particularly thank to Sheng Yang, Yaowu Huang, and Sijian Zhang [MED Department, Carl Zeiss (Shanghai) Co., Ltd., ZEISS Group].

Abbreviations

AUC, area under the curve; CCA, common carotid artery; CeVD, cerebrovascular disease; FAZ, foveal avascular zone; GC-IPL, ganglion cell-inner plexiform layer; GEEs, generalized estimating equations; ICA, internal carotid artery; OA, ophthalmic artery; OCT, optical coherence tomography; OCTA, optical coherence tomography angiography; PD, perfusion density; pRNFL, peripapillary retinal nerve fiber layer; SCP, superficial capillary plexus; VD, vessel density.

References

Arnould, L., Guenancia, C., Azemar, A., Alan, G., Pitois, S., Bichat, F., et al. (2018). The EYE-MI pilot study: a prospective acute coronary syndrome cohort evaluated with retinal optical coherence tomography angiography. Invest. Ophthalmol. Vis. Sci. 59, 4299–4306. doi: 10.1167/iovs.18-24090

PubMed Abstract | CrossRef Full Text | Google Scholar

Buga, A., Di Napoli, M., and Popa-Wagner, A. (2013). Preclinical models of stroke in aged animals with or without comorbidities: role of neuroinflammation. Biogerontology 14, 651–662. doi: 10.1007/s10522-013-9465-0

PubMed Abstract | CrossRef Full Text | Google Scholar

Cheung, N., Mosley, T., Islam, A., Kawasaki, R., Sharrett, A. R., Kelin, R., et al. (2010). Retinal microvascular abnormalities and subclinical magnetic resonance imaging brain infarct: a prospective study. Brain 133, 1987–1993. doi: 10.1093/brain/awq127

PubMed Abstract | CrossRef Full Text | Google Scholar

Couper, D. J., Klein, R., Hubbard, L. D., Wong, T. Y., Sorlie, P. D., Cooper, L. S., et al. (2002). Reliability of retinal photography in the assessment of retinal microvascular characteristics: the atherosclerosis risk in communities study. Am. J. Ophthalmol. 133, 78–88. doi: 10.1016/s0002-9394(01)01315-0

CrossRef Full Text | Google Scholar

DeLong, E. R., DeLong, D. M., and Clarke-Pearson, D. L. (1988). Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837–845. doi: 10.2307/2531595

CrossRef Full Text | Google Scholar

Goebel, W., and Franke, R. (2006). Retinal thickness in diabetic retinopathy: comparison of optical coherence tomography, the retinal thickness analyzer, and fundus photography. Retina 26, 49–57. doi: 10.1097/00006982-200601000-00009

PubMed Abstract | CrossRef Full Text | Google Scholar

Goto, I., Katsuki, S., Ikui, H., Kimoto, K., and Mimatsu, T. (1975). Pathological studies on the intracerebral and retinal arteries in cerebrovascular and noncerebrovascular diseases. Stroke 6, 263–269. doi: 10.1161/01.str.6.3.263

CrossRef Full Text | Google Scholar

Hanff, T. C., Sharrett, A. R., Mosley, T. H., Shibata, D., Knopman, D. S., Kelin, R., et al. (2014). Retinal microvascular abnormalities predict progression of brain microvascular disease: an atherosclerosis risk in communities magnetic resonance imaging study. Stroke 45, 1012–1017. doi: 10.1161/strokeaha.113.004166

PubMed Abstract | CrossRef Full Text | Google Scholar

Jia, Y., Bailey, S. T., Hwang, T. S., McClintic, S. M., Gao, S. S., Pennesi, M. E., et al. (2015). Quantitative optical coherence tomography angiography of vascular abnormalities in the living human eye. Proc. Natl. Acad. Sci. U.S.A. 112, E2395–E2402.

Google Scholar

Kashani, A. H., Chen, C. L., Gahm, J. K., Zheng, F., Richter, G. M., Rosenfeld, P. J., et al. (2017). Optical coherence tomography angiography: a comprehensive review of current methods and clinical applications. Prog. Retin. Eye Res. 60, 66–100. doi: 10.1016/j.preteyeres.2017.07.002

PubMed Abstract | CrossRef Full Text | Google Scholar

Kochanek, K. D., Murphy, S. L., Xu, J., and Arias, E. (2019). Deaths: final data for 2017. Natl. Vital Stat. Rep. 68, 1–77.

Google Scholar

Lammie, G. A. (2002). Hypertensive cerebral small vessel disease and stroke. Brain Pathol. 12, 358–370. doi: 10.1111/j.1750-3639.2002.tb00450.x

PubMed Abstract | CrossRef Full Text | Google Scholar

Li, Y. Y., Guo, R. J., Xie, Y. M., Lin, Y. M., Cai, Y. F., Guo, T., et al. (2020). Expert consensus on Injection of Breviscapine in clinical practice. Zhongguo Zhong Yao Za Zhi 45, 2296–2299.

Google Scholar

McGeechan, K., Liew, G., Macaskill, P., Irwig, L., Klein, R., Klein, E. B. K., et al. (2009). Prediction of incident stroke events based on retinal vessel caliber: a systematic review and individual-participant meta-analysis. Am. J. Epidemiol. 170, 1323–1332. doi: 10.1093/aje/kwp306

PubMed Abstract | CrossRef Full Text | Google Scholar

Menken, M., Munsat, T. L., and Toole, J. F. (2000). The global burden of disease study: implications for neurology. Arch. Neurol. 57, 418–420. doi: 10.1001/archneur.57.3.418

PubMed Abstract | CrossRef Full Text | Google Scholar

Miesfeld, J. B., and Brown, N. L. (2019). Eye organogenesis: a hierarchical view of ocular development. Curr. Top. Dev. Biol. 132, 351–393. doi: 10.1016/bs.ctdb.2018.12.008

PubMed Abstract | CrossRef Full Text | Google Scholar

Mitchell, P., Wang, J. J., Wong, T. Y., Smith, W., Klein, R., and Leeder, S. R. (2005). Retinal microvascular signs and risk of stroke and stroke mortality. Neurology 65, 1005–1009. doi: 10.1212/01.wnl.0000179177.15900.ca

CrossRef Full Text | Google Scholar

Ouyang, Y., Heussen, F. M., Keane, P. A., Sadda, S. R., and Walsh, A. C. (2013). The retinal disease screening study: prospective comparison of nonmydriatic fundus photography and optical coherence tomography for detection of retinal irregularities. Invest. Ophthalmol. Vis. Sci. 54, 1460–1468. doi: 10.1167/iovs.12-10727

PubMed Abstract | CrossRef Full Text | Google Scholar

Pantoni, L. (2010). Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. Lancet Neurol. 9, 689–701. doi: 10.1016/s1474-4422(10)70104-6

CrossRef Full Text | Google Scholar

Paradise, M. B., Shepherd, C. E., Wen, W., and Sachdev, P. S. (2018). Neuroimaging and neuropathology indices of cerebrovascular disease burden: a systematic review. Neurology 91, 310–320. doi: 10.1212/wnl.0000000000005997

PubMed Abstract | CrossRef Full Text | Google Scholar

Rajanala, A. P., Le, H. T., and Gill, M. K. (2020). Central retinal artery occlusion as initial presentation of Moyamoya disease in a middle-aged woman. Am. J. Ophthalmol. Case Rep. 18:100705. doi: 10.1016/j.ajoc.2020.100705

PubMed Abstract | CrossRef Full Text | Google Scholar

Rim, T. H., Teo, A. W. J., Yang, H. H. S., Cheung, C. Y., and Wong, T. Y. (2020). Retinal vascular signs and cerebrovascular diseases. J. Neuroophthalmol. 40, 44–59. doi: 10.1097/wno.0000000000000888

PubMed Abstract | CrossRef Full Text | Google Scholar

Sandu, R. E., Buga, A. M., Uzoni, A., Petcu, E. B., and Popa-Wagner, A. (2015). Neuroinflammation and comorbidities are frequently ignored factors in CNS pathology. Neural Regen. Res. 10, 1349–1355. doi: 10.4103/1673-5374.165208

PubMed Abstract | CrossRef Full Text | Google Scholar

Stenkamp, D. L. (2015). Development of the vertebrate eye and retina. Prog. Mol. Biol. Transl. Sci. 134, 397–414. doi: 10.1016/bs.pmbts.2015.06.006

PubMed Abstract | CrossRef Full Text | Google Scholar

Tomita, Y., Kubis, N., Calando, Y., Tran, D. A., Méric, P., Seylaz, J., et al. (2005). Long-term in vivo investigation of mouse cerebral microcirculation by fluorescence confocal microscopy in the area of focal ischemia. J. Cereb. Blood Flow Metab. 25, 858–867. doi: 10.1038/sj.jcbfm.9600077

PubMed Abstract | CrossRef Full Text | Google Scholar

Wong, T. Y., Klein, R., Couper, D. J., Cooper, L. S., Shahar, E., Hubbard, L. D., et al. (2001). Retinal microvascular abnormalities and incident stroke: the atherosclerosis risk in communities study. Lancet 358, 1134–1140. doi: 10.1016/s0140-6736(01)06253-5

CrossRef Full Text | Google Scholar

Wong, T. Y., Klein, R., Sharrett, A. R., Couper, D. J., Klein, B. E., Liao, D.-P., et al. (2002). Cerebral white matter lesions, retinopathy, and incident clinical stroke. JAMA 288, 67–74. doi: 10.1001/jama.288.1.67

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiao, H., Liu, X., Lian, P., Liao, L. L., and Zhong, Y. M. (2020a). Different damage patterns of retinal nerve fiber layer and ganglion cell-inner plexiform layer between early glaucoma and non-glaucomatous optic neuropathy. Int. J. Ophthalmol. 13, 893–901. doi: 10.18240/ijo.2020.06.06

PubMed Abstract | CrossRef Full Text | Google Scholar

Xiao, H., Liu, X., Liao, L., Tan, K., Ling, Y., and Zhong, Y. (2020b). Reproducibility of foveal avascular zone and superficial macular retinal vasculature measurements in healthy eyes determined by two different scanning protocols of optical coherence tomography angiography. Ophthalm. Res. 63, 244–251. doi: 10.1159/000503071

PubMed Abstract | CrossRef Full Text | Google Scholar

Zhang, X., Xiao, H., Liu, C., Zhao, L., and Wang, J. (2020). Comparison of macular structural and vascular changes in neuromyelitis optica spectrum disorder and primary open angle glaucoma: a cross-sectional study. Br. J. Ophthalmol. doi: 10.1136/bjophthalmol-2020-315842 [Epub ahead of print].

CrossRef Full Text | PubMed Abstract | Google Scholar